Thomas Pollak

9.4k total citations · 1 hit paper
101 papers, 3.9k citations indexed

About

Thomas Pollak is a scholar working on Neurology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, Thomas Pollak has authored 101 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Neurology, 24 papers in Psychiatry and Mental health and 20 papers in Biological Psychiatry. Recurrent topics in Thomas Pollak's work include Autoimmune Neurological Disorders and Treatments (37 papers), Peripheral Neuropathies and Disorders (23 papers) and Tryptophan and brain disorders (20 papers). Thomas Pollak is often cited by papers focused on Autoimmune Neurological Disorders and Treatments (37 papers), Peripheral Neuropathies and Disorders (23 papers) and Tryptophan and brain disorders (20 papers). Thomas Pollak collaborates with scholars based in United Kingdom, United States and Germany. Thomas Pollak's co-authors include Anthony S. David, Philip McGuire, Jonathan Rogers, Michael S. Zandi, Glyn Lewis, Paolo Fusar‐Poli, Edward Chesney, Dominic Oliver, Timothy R. Nicholson and Belinda Lennox and has published in prestigious journals such as Journal of Neuroscience, Brain and Neurology.

In The Last Decade

Thomas Pollak

94 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

2020 1.6k citations Jonathan Rogers, Thomas Pollak et al. The Lancet Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Pollak United Kingdom	26	2.1k	1.4k	767	683	426	101	3.9k
Michael S. Zandi United Kingdom	18	2.4k 1.1×	1.2k 0.8×	237 0.3×	455 0.7×	418 1.0×	60	3.3k
Sandra López‐León United States	22	1.9k 0.9×	1.2k 0.8×	178 0.2×	541 0.8×	889 2.1×	53	3.6k
Benedetta Vai Italy	28	989 0.5×	1.1k 0.8×	626 0.8×	759 1.1×	238 0.6×	75	2.9k
Jessica Gill United States	41	1.8k 0.8×	1.0k 0.7×	401 0.5×	369 0.5×	57 0.1×	165	5.5k
Irene Bollettini Italy	21	714 0.3×	824 0.6×	472 0.6×	709 1.0×	144 0.3×	42	2.2k
Siew E. Chua Hong Kong	29	515 0.2×	1.9k 1.3×	194 0.3×	1.0k 1.5×	111 0.3×	42	4.3k
Daniel Kondziella Denmark	29	1.2k 0.6×	204 0.1×	278 0.4×	549 0.8×	104 0.2×	151	3.1k
Ildebrando Appollonio Italy	32	1.2k 0.6×	205 0.1×	115 0.1×	875 1.3×	176 0.4×	167	4.2k
Belinda Lennox United Kingdom	33	779 0.4×	654 0.5×	993 1.3×	1.5k 2.2×	84 0.2×	112	4.3k
Golam M. Khandaker United Kingdom	36	314 0.1×	914 0.6×	3.9k 5.1×	1.6k 2.3×	97 0.2×	126	6.9k

Countries citing papers authored by Thomas Pollak

Since Specialization

Citations

This map shows the geographic impact of Thomas Pollak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Pollak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Pollak more than expected).

Fields of papers citing papers by Thomas Pollak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Pollak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Pollak. The network helps show where Thomas Pollak may publish in the future.

Co-authorship network of co-authors of Thomas Pollak

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Pollak. A scholar is included among the top collaborators of Thomas Pollak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Pollak. Thomas Pollak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramírez‐Bermúdez, Jesús, Mariana Espínola-Nadurille, Verónica Rivas‐Alonso, et al.. (2025). Autoimmune psychosis: Psychopathological patterns and outcome after immunotherapy. Schizophrenia Research. 281. 10–19. 3 indexed citations

Blackman, Graham, Robert A. Byrne, Vaughan Bell, et al.. (2025). How common is secondary psychosis? Estimates from a systematic review and meta‐analysis. World Psychiatry. 24(1). 145–146. 3 indexed citations

Pollak, Thomas, David D’Cruz, Elliott Lever, et al.. (2025). A randomised controlled trial to assess the feasibility and acceptability of remote psychosocial and exercise interventions for people with lupus: The ADAPT feasibility trial. Rheumatology International. 45(10). 233–233. 1 indexed citations

Watson, Cameron, et al.. (2025). Childhood adversity as a risk factor for autoimmune disease: A systematic review and meta-analysis with implications for psychiatry. Brain Behavior and Immunity. 128. 643–653.

Pollak, Thomas, Efthalia Massou, Felix Naughton, et al.. (2025). Self-reported cognitive dysfunction and memory impairment in Systemic Autoimmune Rheumatic Diseases (SARDs): a mixed methods analysis of the INSPIRE cohort. Lara D. Veeken. 64(12). 6213–6223. 1 indexed citations

Sloan, Melanie, Thomas Pollak, Efthalia Massou, et al.. (2024). Neuropsychiatric symptoms in systemic lupus erythematosus: mixed methods analysis of patient-derived attributional evidence in the international INSPIRE project. Lara D. Veeken. 64(3). 1179–1192. 4 indexed citations

Ramírez‐Bermúdez, Jesús, Mariana Espínola-Nadurille, Laura E. Hernández‐Vanegas, et al.. (2023). Examining the Features of Neuroleptic Malignant Syndrome in Anti-NMDA Receptor Encephalitis: A Case-Control Study. Journal of the Academy of Consultation-Liaison Psychiatry. 65(3). 222–230. 3 indexed citations

Chung, Raymond T., John Lally, Grant McQueen, et al.. (2023). Changes in immunoglobulin levels during clozapine treatment in schizophrenia. Brain Behavior and Immunity. 115. 223–228. 10 indexed citations

Sloan, Melanie, Chris Wincup, Rupert Harwood, et al.. (2023). Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study. Lara D. Veeken. 63(5). 1259–1272. 17 indexed citations

10.

Blackman, Graham, Thomas Pollak, Adam Al‐Diwani, et al.. (2022). The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data. Journal of Neurology. 269(10). 5302–5311. 7 indexed citations

11.

Badenoch, James, Isabella Conti, Emma Rengasamy, et al.. (2022). Neurological and psychiatric presentations associated with human monkeypox virus infection: a systematic review and meta-analysis. medRxiv. 11 indexed citations

12.

Mariaselvam, Christina Mary, Ching‐Lien Wu, Wahid Boukouaci, et al.. (2021). The Complement C4 Genetic Diversity in First Episode Psychosis of the OPTiMiSE Cohort. Schizophrenia Bulletin Open. 2(1). 4 indexed citations

13.

Pollak, Thomas, Angela Vincent, Conrad Iyegbe, et al.. (2020). Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis. Biological Psychiatry. 90(1). 9–15. 16 indexed citations

14.

Endres, Dominique, Viktoria Maier, Frank Leypoldt, et al.. (2020). Autoantibody-associated psychiatric syndromes: a systematic literature review resulting in 145 cases. Psychological Medicine. 52(6). 1135–1146. 43 indexed citations

15.

Décary-Hêtu, David, et al.. (2019). Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis. International Journal of Drug Policy. 73. 263–272. 27 indexed citations

16.

Lennox, Belinda, Thomas Pollak, & Angela Vincent. (2019). An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin: the concept of autoimmune psychosis. The Lancet Psychiatry. 3 indexed citations

17.

Pollak, Thomas, Adam Al‐Diwani, & Belinda Lennox. (2017). Neuronal surface autoantibodies, encephalitis, and psychosis: from neurology to psychiatry. Research Portal (King's College London). 3 indexed citations

18.

Waterhouse, Mary, David C. Whiteman, Richard J. Johns, et al.. (2016). Comparison of PTCH1, COX‐2, p53, and Ki‐67 protein expression in basal cell carcinomas of nodular and superficial subtypes arising on the head and trunk. International Journal of Dermatology. 55(10). 1096–1105. 3 indexed citations

19.

Pollak, Thomas, Timothy R. Nicholson, John D. C. Mellers, Angela Vincent, & Anthony S. David. (2014). Epilepsy-related psychosis: A role for autoimmunity?. Epilepsy & Behavior. 36. 33–38. 20 indexed citations

20.

Pollak, Thomas, Ruaidhrí McCormack, Mark Peakman, Timothy R. Nicholson, & Anthony S. David. (2013). Prevalence of anti-N-methyl-d-aspartate (NMDA) receptor antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Psychological Medicine. 44(12). 2475–2487. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact